早期透明细胞卵巢癌与高级别组织学亚型的结局比较:两家肿瘤中心的探索性分析
该研究纳入两家意大利肿瘤中心1981至2012年治疗的早期高级别卵巢癌患者,比较早期透明细胞卵巢癌(CCOC)与高级别子宫内膜样(HGE)和浆液性(HGS)卵巢癌在无复发生存间隔(RFI)、癌特异性生存(CSS)和复发后癌特异性生存(prCSS)上的差异。CCOC较HGSOC有更长的RFI、相似的CSS但更短的prCSS,与HGE无预后差异。
要点
- 早期CCOC较HGSOC有更长的RFI,但复发后生存更差。
- 辅助化疗显著改善RFI(aHR 0.61,95%CI 0.40-0.91,P=0.015)。
- IA/IB/IC1期CCOC较同期HGSOC复发风险更低,但复发后预后更差。
核心结论
- 早期CCOC与HGSOC相比RFI更长、CSS相似但prCSS更短,与HGE无预后差异。
- 复发后CCOC对化疗敏感性差,导致复发后生存较短。
研究设计与样本
- 回顾性队列研究,纳入两家意大利肿瘤中心1981至2012年治疗的早期高级别卵巢癌患者。
- 共纳入134例CCOC、152例HGE和160例HGS患者,中位随访11.5年。
- 采用Cox比例风险模型和限制性平均生存时间进行分析。
主要发现
- 辅助化疗显著改善RFI(aHR 0.61,95%CI 0.40-0.91,P=0.015)。
- 多变量分析中,HGS组织型较CC与更短RFI相关(HR 1.81,95%CI 1.12-2.93,P=0.016),CSS无统计学差异。
- HGS较CCOC的prCSS更长(HR 0.36,95%CI 0.17-0.74,P=0.006)。
- 按分期,IA/IB/IC1期HGSOC较同期CCOC的RFI更短(HR 2.13,95%CI 1.14-3.99,P=0.018),但CSS相似;无论初始分期,CC较HGS的prCSS预后更差。
临床怎么用
- 早期CCOC患者复发风险较低,但复发后预后差,需加强复发监测和后续治疗策略探索。
- 辅助化疗可改善早期高级别卵巢癌的RFI,支持其临床应用。
局限性
- 回顾性研究设计,样本来自两家中心,可能存在选择偏倚。
- 探索性分析,结果需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: advanced stage clear cell ovarian cancer (CCOC) carries a higher risk of relapse and death compared to other histological subtypes. The prognosis of early-stage CCOC is controversial. METHODS: Early-stage high-grade OC patients from two Italian oncologic centers were included. Patients with early-stage CCOC were compared with those with high-grade endometrioid (HGE) and serous (HGS) OC in terms of relapse-free interval (RFI), cancer-specific survival (CSS) and post relapse cancer-specific survival (prCSS). The Cox proportional hazard model and the restricted mean survival time were used. RESULTS: Between 1981 and 2012, 134 patients with CC, 152 with HGE and 160 with HGS were treated at two referral centers. Median follow-up was 11.5 years. Ten years RFI rates were 80.6%, 72.1%, 60.6%, and CSS rates were 84.3%, 82.6%, 81.7% respectively. Adjuvant chemotherapy significantly improved RFI (aHR 0.61, 95%CI 0.40 to 0.91, P = 0.015). In the multivariable analysis HGS histotype was associated with a shorter RFI compared to CC, (Hazard Ratio [HR]: 1.81; 95%CI: 1.12-2.93; P = 0.016), whereas CSS was not statistically different. prCSS was longer in HGS compared to CCOC (HR, 0.36; 95% CI, 0.17-0.74; P = 0.006). According to the stage, IA/IB/IC1 HGSOC had a shorter RFI (HR, 2.13; 95% CI, 1.14-3.99; P = 0.018) compared to IA/IB/IC1 CCOC, but similar CSS. For prCSS, CC compared to HGS conferred a worse prognosis regardless of the initial stage. CONCLUSIONS: Early-stage CCOC is associated with a longer RFI, similar CSS and a shorter prCSS compared to HGSOC. No prognostic differences were observed between CC and HGE OC. The relapse risk was the lowest in IA/IB/IC1 CC compared to HGS, whereas CC displayed poor sensitivity to chemotherapy after relapse.
引用
- Ceppi L, Grassi T, Galli F, et al. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers. Gynecol Oncol. 2020. PMID: 33077259. doi:10.1016/j.ygyno.2020.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。